Skip to content
CancerIndex

Publication

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.

Authors not recorded

Haematologica2009PMID 19059939PMC2625424stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (4)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 4

Curated evidence

Evidence citing this paper (3)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
19059939
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–3 of 3 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
NPM1 EXON 11 MUTATION3
(diagnostic)Acute Myeloid LeukemiaCURATED_BROADERDiagnosticBSupports Positive3accepted
EID120

NPM1 mutations were associated with normal karyotype in older (>60) patients.

PMID 19059939 · Schlenk et al., 2009 · Open in CIViC

civic
(prognostic)Acute Myeloid LeukemiaCURATED_BROADERPrognosticBSupports Better Outcome3accepted
EID174

Patients with NPM1 mutations were associated with improved complete remission rates as well as overall and disease free survival when all ages and karyotype were analyzed; however, when only normal ka… (full text at CIViC)

PMID 19059939 · Schlenk et al., 2009 · Open in CIViC

civic
TretinoinAcute Myeloid LeukemiaCURATED_BROADERPredictiveBSupports Sensitivity Response2accepted
EID146

ATRA treatment improved overall and relapse-free survival in older (>60) patients with mutant NPM1 and without FLT3-ITD.

PMID 19059939 · Schlenk et al., 2009 · Open in CIViC

civic